Big-Pharma Vaccines Deemed “Safe” by Big-Pharma Funded “Study”

Region:

RT’s article, “Vaccines don’t cause autism, complications extremely rare – study,” states that:

There is no evidence that immunizing vaccinations cause autism while any complications arising from their administration to children are extremely rare, new analysis comprised of 67 research studies has discovered.

“There is strong evidence that MMR (Measles, Mumps, and Rubella) vaccine is not associated with autism,”the study’s results said.

RT cites a “Pediatrics: Official Journal of the American Academy of Pediatrics” study titled, “Safety of Vaccines Used for Routine Immunization of US Children: A Systematic Review,” which claims:

We found evidence that some vaccines are associated with serious AEs [adverse effects]; however, these events are extremely rare and must be weighed against the protective benefits that vaccines provide.

The report’s conclusions are hardly convincing. But what’s more troubling, is the immense conflict of interest from which the report itself was written. The authors belong to the corporate-funded think tank, RAND Corporation.

While the report itself was funded by the US government, the RAND Corporation from which its authors were drawn is funded by the very corporations (.PDF page 70) that manufacture various vaccines, including the MMR vaccine which was the primary focus of the report. Big-pharma sponsors of RAND include GlaxoSmithKline (GSK) and Merck – that latter of which is listed by the US Center for Disease Control (CDC) specifically as the manufacturer of the MMR vaccine.

Merck has also directly and openly funded other studies put out by RAND (here and here). RAND’s other big-pharma sponsor, GSK, has been recently exposed amid a global multi-billion dollar bribing scandal where it was paying off doctors to endorse and distribute their products.With Pediatrics’ report exposed as – at the very least – an irresponsible, unethical exercise in research, and at worst, corporate propaganda masquerading as a scientific paper, those considering whether or not to have vaccines manufactured by deceitful pharmaceutical monopolies injected into their bodies, have an added incentive to hold off and search for alternatives.

While the science of vaccinations may be sound, the corporations that have monopolized their manufacturing and distribution are often dishonest. The debate is not necessarily whether the process of vaccinating is good or bad, but why enterprises have monopolized that process and what can be done to stop them. As with everything else corporate monopolies do, there is a hidden agenda behind the drive to whitewash and promote big-pharma’s vaccines – an agenda that may transcend mere profits and demands additional scrutiny. If commentators want to assign blame upon anyone for creating public distrust in vaccines, it should be upon big-pharma itself.

Articles by: Tony Cartalucci

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]